Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2020

View Archived Issues

CEPI announces first-ever phase I study of Nipah virus vaccine candidate

ABCA1 mutations promote tumor progression in myeloid neoplasms

Tolerizing DCs are made, not born

Topline data from COUGH-1 and COUGH-2 studies of gefapixant

Brilacidin to be evaluated as potential COVID-19 vaccine

First-in-human trial of HH-2710 in patients with advanced tumors

First patient dosed in phase I/Ib of the antibody candidate SRF-617

Positive data from bioequivalence study of ET-101

Morphic Therapeutic describes new integrin alphavbeta6 antagonists

Ultupharma discovers new antibacterials

New aryl hydrocarbon receptor antagonists disclosed by JAGUAHR Therapeutics

Xenon Pharmaceuticals identifies sodium channel protein type 8 subunit alpha blockers

PD-1/PD-L1 interaction inhibitors patented by Shenzhen Chipscreen Biosciences

Mortalin as a new therapeutic target for B-Raf-mutant or MEK/ERK-driven tumors

Researchers unveil GluN2A targeting as therapeutic strategy for treating SLE-derived neuropathy

Risk factors for mortality in adult patients with COVID-19

Organ microbiomes associated with diabetes risk

Grant supports clinical evaluation of Vaxxas' HD-MAP platform for measles and rubella vaccination

Italian trial evaluates siltuximab for COVID-19 patients with serious respiratory complications

Synairgen receives U.K. clearances to study SNG-001 in patients with COVID-19

SignPath to explore utility of Lipocurc for ARDS

Enzychem advances EC-18 as coronavirus treatment candidate

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...